Fulcrum Therapeutics Inc (FULC)
Cost of Revenue
$14.55M
TTM · Period ending: · USD
FULC Cost of Revenue
Latest reported$14.55Mperiod ending
Latest reported$14.55Mperiod ending
FULC TTM Cost of Revenue ($0.00 → $14.55M)
TTM cost of revenue
High-resolution chart · PNG
FULC cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 14,550,000 | |
| 14,634,000 | |
| 27,700,000 | |
| 28,369,000 | |
| 28,712,000 | |
| 45,673,000 | |
| 32,748,000 | |
| 32,887,000 | |
| 36,486,000 | |
| 37,074,000 | |
| 53,310,000 | |
| 71,368,000 | |
| 68,496,000 | |
| 75,666,000 | |
| 76,782,000 | |
| 77,128,000 | |
| 78,839,000 | |
| 71,198,000 | |
| 69,701,000 | |
| 66,934,000 | |
| 65,497,000 | |
| 60,894,000 | |
| 59,042,000 | |
| 43,416,000 | |
| 41,272,000 | |
| 39,357,000 | |
| 59,504,000 | |
| 58,985,000 | |
| 45,489,000 | |
| 34,629,000 | |
| 0 |